Panaxia Pharmaceutical Industries specializes in the research, development, and manufacturing of medical cannabis.

The company's goal is to align medical cannabis with formulation technologies and the highest available pharmaceutical standards.

Panaxia currently manufactures a variety of standardized medical cannabis products including sublingual and oral tablets, metered-dose inhalers, creams, and suppositories.

The company's products, manufacturing facility, and production processes are subject to stringent quality assurance procedures.

Panaxia is part of the Panaxia Medical Devices and Pharmaceuticals Group.

Panaxia's R&D center is located in Israel and is managed by senior scientists and graduates of the Weizmann Institute of Science.Panaxia offers more than 600 medical products in over 30 international markets to treat a wide range of symptoms and conditions.